Table 2.
Anthropometry, renal function, cardiac status at the time of admission to the hospital, percutaneous coronary intervention (pci)-related parameters, in-hospital outcome and cardiac risk factors in the patients with and without ami-induced ptsd symptomatology
| Category | Total Sample (n = 114) |
p | PTSD-Symptomatology (n = 49/114; 43%) | No PTSD (n = 65/114; 57%) |
||
|---|---|---|---|---|---|---|
| Anthropometry | ||||||
| Height (cm) | Mean (SD) | 174.79 (±8.15) | - | 173.5 (±8.27) | 176.0 (±7.97) | t = 1.435, df = 109 p = 0.154a |
| Weight (kg) | Mean (SD) | 86.64 (±13.89) | - | 87.7 (±16.82) | 85.81 (±11.20) | t = −0.710, df = 108 p = 0.479a |
| BMI | Mean (SD) | 28.31 (±-4.0) | - | 29.01 (±4.89) | 27.76 (±3.07) | t = −1.643, df = 108 p = 0.103a |
| Renal Function | ||||||
| Glomerular Filtration Rate | Mean (SD) | 84.69 (±17.87) | - | 83.6 (±18.89) | 85.53 (±17.17) | t = 0.578, df = 112 p = 0.56a |
| Cardiac Situation at the Time of Admission to the Hospital | ||||||
| NSTEMI | n (%) | 43 (37.7%) | - | 20 (40.8%) | 23 (35.4%) | χ2 = 0.351, df = 1 p = 0.55b |
| STEMI | n (%) | 71 (62.3%) | 29 (59.2%) | 42 (64.6%) | ||
| Killip Mortality Risk Stratification: | ||||||
| Killip Class I | n (%) | 88 (77.2%) | χ2 = 197.62, df = 3 p < .001a |
40 (85.1%) | 48 (84.2%) | χ2 = 0.807, df = 3 p = 0.85b |
| Killip Class II | n (%) | 8 (7%) | 3 (6.4%) | 5 (8.8%) | ||
| Killip Class III | n (%) | 5 (4.4%) | 2 (4.3%) | 3 (5.3%) | ||
| Killip Class IV | n (%) | 3 (2.6) | 2 (4.3%) | 1 (1.8%) | ||
| Abnormal Level of Troponin T |
n (%) | 114 (100%) | - | 49 (100%) | 65 (100%) | - |
| Cardiogenic Shock | n (%) | 0 (%) | - | 0 (0%) | 0 (0%) | - |
| AMI-related Reanimation | n (%) | 3 (2.6%) | - | 2 (4.1%) | 1 (1.5%) | p = 0.576c |
| PCI-related Parameters | ||||||
| TIMI Flow before PCI: | ||||||
| 0-I | n (%) | 85 (74.6%) | χ2 = 108.571.62, df = 2 p < .001a |
35 (76.1%) | 50 (84.7%) | χ2 = 1.325, df = 2 p = 0.52b |
| II | n (%) | 15 (13.2%) | 8 (17.4%) | 7 (11.9%) | ||
| III | n (%) | 5 (4.4%) | 3 (6.5%) | 2 (3.4% | ||
| TIMI flow after PCI: | ||||||
| 0-I | n (%) | 4 (3.5%) | χ2 = 156.054.62, df = 2 p < .001a |
0 (0%) | 4 (6.3%) | χ2 = 4.269, df = 2 p = 0.12b |
| II | n (%) | 8 (7%) | 5 (10.6%) | 3 (4.7%) | ||
| III | n (%) | 99 (86.8%) | 42 (89.4%) | 57 (89.0%) | ||
| Multivessel PCI | n (%) | 23 (20.2%) | - | 13 (27.7%) | 10 (16.7%) | χ2 = 1.887, df = 1 p = 0.17b |
| Coronary Artery Disease (number of affected vessels) | Mean (SD) | 1.82 (±0.79) | 1.84 (±0.83) | 1.82 (±0.76) | t-test = −0.074, df = 112 p = 0.89a |
|
| In-hospital Outcome | ||||||
| Major Bleeding | n (%) | 0 (0%) | - | 0 (0%) | 0 (0%) | - |
| Reinfarction | n (%) | 2 (1.8%) | - | 1 (2.0%) | 1 (1.5%) | χ2 = 0.042, df = 1 p = 0.84b |
| Left-Ventricular Ejection Fraction (%) | Mean (SD) | 53.15 (±10.559) | - | 53.24 (±11.73) | 53.07 (±9.60) | t-test = −0.074, df = 79 p = 0.94a |
| Cardiac Risk Factors | ||||||
| Nicotine Abuse | n (%) | 39 (34.2%) | - | 23 (46.9%) | 30 (46.2%) | χ2 = 0.007, df = 1 p = 0.93b |
| Peripheral Arterial Occlusive Disease | n (%) | 3 (2.6%) | - | 2 (4.1%) | 1 (1.5%) | χ2 = 0.681, df = 1 p = 0.41b |
| IDDM | n (%) | 2 (1.8%) | - | 1 (2.0%) | 1 (1.5%) | χ2 = 0.041, df = 1 p = 0.84b |
| NIDDM | n (%) | 17 (14.9%) | - | 11 (22.4%) | 6 (9.2%) | χ2 = 3.847, df = 1 p = 0.05b |
| Hypertension | n (%) | 102 (89.5%) | - | 42 (85.7%) | 60 (92.3%) | χ2 = 1.290, df = 1 p = 0.26b |
| Hyperlipidaemia | n (%) | 59 (51.8%) | - | 28 (56.0%) | 31 (47.7) | χ2 = 1.077, df = 1 p = 0.30b |
| Relevant Family History | n (%) | 23 (20.2%) | - | 10 (23.3%) | 13 (25.5%) | χ2 = 0.063, df = 1 p = 0.80b |
| Previous Myocardial Infarction | n (%) | 12 (10.5%) | - | 8 (16.3%) | 4 (6.5%) | χ2 = 2.768, df = 1 p = 0.096 |
| Severe Liver Disease | n (%) | 2 (1.8%) | - | 0 (0%) | 2 (3.0%) | χ2 = 1.54, df = 1 p = 0.22b |
Legend: a t-test; b χ2 – test, c Fisher exact; Abbreviations: AMI = Acute Myocardial Infarction; IDDM = Insulin-dependent Diabetes Mellitus; NIDDM = Non-Insulin-dependent Diabetes Mellitus; PCI = Percutaneous Coronary Intervention; TIMI flow = Thrombolysis in Myocardial Infarction Flow.